ТАКТИКА ВЕДЕНИЯ ПАЦИЕНТОК С ДИСПАРЕУНИЕЙ В ПОСТМЕНОПАУЗЕ: ВОССТАНОВЛЕНИЕ СЕКСУАЛЬНОГО ЗДОРОВЬЯ И КАЧЕСТВА ЖИЗНИ»

1. Cagnacci A., Carbone M.M., Palma F. Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study. Menopause. 2016; 23(10): 1139‑45. https://dx.doi.org/10.1097/GME.0000000000000675

2. Freedman M.A. Perceptions of dyspareunia in postmenopausal women with vulvar and vaginal atrophy: findings from the REVIVE survey. Womens Health (Lond.). 2014; 10(4): 445‑54. https://dx.doi.org/10.2217/whe.14.29

3. Tayyeb M., Gupta V. Dyspareunia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.

4. Traish A.M., Vignozzi L., Simon J.A., Goldstein I., Kim N.N. Role of androgens in female genitourinary tissue structure and function: implications in the genitourinary syndrome of menopause. Sex. Med. Rev. 2018; 6(4): 558‑71. https://dx.doi.org/10.1016/j.sxmr.2018.03.005

5. Arora V., Mukhopadhyay S., Morris E. Painful sex (dyspareunia): a difficult symptom in gynecological practice. Obstet. Gynaecol. Reprod. Med. 2020; 30(9): 269‑75. https://dx.doi.org/10.1016/j.ogrm.2020.06.001

6. Li T., Ma Y., Zhang H., Yan P., Huo L., Hu Y. et al. Estrogen replacement regulates vaginal innervations in ovariectomized adult virgin rats: a histological study. Biomed. Res. Int. 2017; 2017: 7456853. https://dx.doi.org/10.1155/2017/7456853

7. Mónica Brauer M., Smith P.G. Estrogen and female reproductive tract innervation: cellular and molecular mechanisms of autonomic neuroplasticity. Auton. Neurosci. 2015; 187: 1‑17. https://doi.org/10.1016/j.autneu.2014.11.009

8. Ting A.Y., Blacklock A.D., Smith P.G. Estrogen regulates vaginal sensory and autonomic nerve density in the rat. Biol. Reprod. 2004; 71(4): 1397‑404. https://doi.org/10.1095/biolreprod.104.030023

9. Beck L.A., Cork M.J., Amagai M., De Benedetto A., Kabashima K., Hamilton J.D. et al. Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov. 2022; 2(5): 100131. https://dx.doi.org/10.1016/j.xjidi.2022.100131

10. Takahashi S., Ishida A., Kubo A., Kawasaki H., Ochiai S., Nakayama M. et al. Homeostatic pruning and activity of epidermal nerves are dysregulated in barrier‑impaired skin during chronic itch development. Sci. Rep. 2019; 9(1): 8625. https://dx.doi.org/10.1038/s41598‑019‑44866‑0

11. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Менопауза и климактерическое состояние у женщины. М.; 2021. 86 с.

12. Mac Bride M.B., Rhodes D.J., Shuster L.T. Vulvovaginal atrophy. Mayo Clin. Proc. 2010; 85(1): 87‑94. https://dx.doi.org/10.4065/mcp.2009.0413

13. Nappi R.E., Martini E., Cucinella L., Martella S., Tiranini L., Inzoli A. et al. Addressing vulvovaginal atrophy (VVA) / genitourinary syndrome of menopause (GSM) for healthy aging in women. Front. Endocrinol. (Lausanne). 2019; 10: 561. https://dx.doi.org/10.3389/fendo.2019.00561

14. Weber M.A., Limpens J., Roovers J.P. Assessment of vaginal atrophy: a review. Int. Urogynecol. J. 2015; 26(1): 15‑28. https://dx.doi.org/10.1007/s00192‑014‑2464‑0

15. Barton D.L., Sloan J.A., Shuster L.T., Gill P., Griffin P., Flynn K. et al. Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support. Care Cancer. 2018; 26(2): 643‑50. https://dx.doi.org/10.1007/s00520‑017‑3878‑2

16. Инструкция по применению лекарственного препарата для медицинского применения Мойстана® (Moistana)

17. Инструкция по применению лекарственного препарата для медицинского применения Интрароса® (Intrarosa®)

18. Bouchard C., Labrie F., Derogatis L., Girard G., Ayotte N., Gallagher J. et al. Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC‑230 open‑label study. Horm. Mol. Biol. Clin. Investig. 2016; 25(3): 181‑90. https://dx.doi.org/10.1515/hmbci‑2015‑0044